Alpine Immune Sciences Analysis: $508M Raised
What is Alpine Immune Sciences?
Alpine Immune Sciences develops novel protein-based cancer immunotherapies using its proprietary variant ig domain platform technology. The company focuses on enhancing engineered cellular therapies through its TIP technology, which interacts with multiple targets in the immune synapse.
Location
188 E Blaine St, Seattle, Washington 98102, United States
Employees
11-50
Founded
2015
Product Features & Capabilities
- TIP technology for engineered cellular therapies
- Proprietary variant ig domain platform
- Cancer immunotherapy development
Use Cases
Develop cancer immunotherapies targeting immune synapse; Enhance cellular therapies for oncology applications; Utilize proprietary technology for multiple immune targets
How much Alpine Immune Sciences raised
Funding - $508M
See something that needs updating? Suggest edits to this profile.